Daniel Aghion insider trades
Open-market stock purchases and sales by Daniel Aghion, Director at Oramed Pharmaceuticals Inc, from SEC Form 4 filings since Jan 4, 2024.
Companies traded
- ORMP Oramed Pharmaceuticals Inc: other filings, last Dec 31, 2025